Long‐term outcomes of status epilepticus: A critical assessment

2018/08/26 by Claudine Sculier, Marina Gaínza‐Lein, Iván Sánchez Fernández +1 · 25 citations
Medicine · #Epilepsy research and treatment #Pharmacological Effects and Toxicity Studies #Drug Transport and Resistance Mechanisms

paper · pdf · doi:10.1111/epi.14515

Abstract

We reviewed 37 studies reporting long-term outcomes after a status epilepticus (SE) episode in pediatric and adult populations. Study design, length of follow-up, outcome measures, domains investigated (mortality, SE recurrence, subsequent epilepsy, cognitive outcome, functional outcome, or quality of life), and predictors of long-term outcomes are summarized. Despite heterogeneity in the design of prior studies, overall risk of poor long-term outcome after SE is high in both children and adults. Etiology is the main determinant of outcome, and the effect of age or SE duration is often difficult to distinguish from the underlying cause. The effect of the treatment on long-term outcome after SE is still unknown.

Citations

• Early developmental outcomes in children following convulsive status epilepticus: A longitudinal study
• Long‐term follow‐up of febrile infection–related epilepsy syndrome
• Functional and Cognitive Outcome in Prolonged Refractory Status Epilepticus

Cited by

• The Neuroprotective Effect of Astaxanthin on Pilocarpine-Induced Status Epilepticus in Rats. [europepmc]
• Pharmacotherapy for Pediatric Convulsive Status Epilepticus. [europepmc]
• Markers in Status Epilepticus Prognosis. [europepmc]
• Familial aggregation of status epilepticus in generalized and focal epilepsies. [europepmc]
• Time-Dependent Impairment of Fear Conditioning and Associated Brain Regions After Pilocarpine-Induced Status Epilepticus. [europepmc]
• Clinical Feature and Outcome of Childhood Status Epilepticus in a Teaching Hospital, Odisha, India. [europepmc]
• Coronavirus Infections in the Nervous System of Children: A Scoping Review Making the Case for Long-Term Neurodevelopmental Surveillance. [europepmc]
• Continuous EEG use and status epilepticus treatment in Australasia: a practice survey of Australian and New Zealand epileptologists. [europepmc]
• Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus. [europepmc]
• Epidemiology and Outcomes of Status Epilepticus. [europepmc]
• Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with Drug-Resistant Temporal Lobe Epilepsy of Unknown Etiology. [europepmc]
• Risk factors associated with short-term mortality and recurrence of status epilepticus in dogs. [europepmc]
• Predictors of high functional disability and mortality at 3 months in patients with status epilepticus. [europepmc]
• Prediction of Long-term Survival After Status Epilepticus Using the ACD Score. [europepmc]
• Disability and Mortality in Convulsive Status Epilepticus in Children at 3 Months' Follow-Up: A Prospective Study from India. [europepmc]
• Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: Systematic review. [europepmc]
• Hospital EEG Capability and Associations With Interhospital Transfer in Status Epilepticus. [europepmc]
• Evaluating salvage electroconvulsive therapy for the treatment of prolonged super refractory status epilepticus: A case series. [europepmc]
• The lactate receptor HCAR1: A key modulator of epileptic seizure activity. [europepmc]
• Stiripentol for the treatment of refractory status epilepticus. [europepmc]
• New onset refractory status epilepticus: Long-term outcomes beyond seizures. [europepmc]
• Medications used for seizure-emergency management in the UK community: A clinical practice research datalink retrospective database study. [europepmc]
• Midazolam Oromucosal Solution for the Management of Prolonged Convulsive Seizures in Adult Outpatients: Addressing Unmet Needs in Europe. [europepmc]
• Epidemiology of Status Epilepticus in Kazakhstan: A 10-Year Population-Based Study. [europepmc]
• Peri-Ictal MRI Abnormalities and Risk of Unprovoked Seizures After De Novo Status Epilepticus. [europepmc]

Related

• Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation
• Epidemiology of status epilepticus in adults: A population‐based study on incidence, causes, and outcomes
• Functional and Cognitive Outcome in Prolonged Refractory Status Epilepticus
• Refractory status epilepticus: A prospective observational study
• Prognostic factors and impact of management strategies for status epilepticus: The STEPPER study in the Emilia‐Romagna region, Italy